Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults with Amyotrophic Lateral Sclerosis A Randomized Clinical Trial
JAMA neurology(2023)
Key words
Spinal Muscular Atrophy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined